Trial Profile
A PhaseII Study of JTE-052 Ointment in Pediatric Patients with Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jan 2022
Price :
$35
*
At a glance
- Drugs Delgocitinib (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors Japan Tobacco
- 16 Aug 2019 Results published in the Journal of Allergy and Clinical Immunology
- 15 Feb 2018 Status changed from active, no longer recruiting to completed.
- 08 Sep 2017 Status changed from recruiting to active, no longer recruiting.